Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol
The growing attention to alternative glycemic biomarkers including fructosamine, glycated albumin (GA), 1,5-anhydroglucitol (1,5-AG), is attributable to the limitations of the glycated hemoglobin (HbA1c) assay. It is important to recognize the conditions in which HbA1c levels may be difficult to int...
Saved in:
Main Author: | Ji-Eun Lee (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pediatric Endocrinology,
2015-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum glycated albumin as a new glycemic marker in pediatric diabetes
by: Ji Woo Lee, et al.
Published: (2013) -
Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy
by: Luiza Cristina Gobor, et al.
Published: (2021) -
Value of serum 1,5-anhydroglucitol measurements in childhood obesity in the continuum of diabetes
by: Ha Yeong Yoo, et al.
Published: (2015) -
Serum fructosamine a better indicator than glycated hemoglobin for monitoring gestational diabetes mellitus
by: S Ayyappan, et al.
Published: (2015) -
1,5-Anhydroglucitol in type 2 diabetes mellitus patients with ST elevation myocardial infarction.
by: Dinara Sheryazdanova, et al.
Published: (2021)